New cancer drug enters human testing for advanced tumors
Disease control
Terminated
This early-stage study tested a new cancer drug called IBI3004 in adults with advanced solid tumors that cannot be removed by surgery. The main goal was to find the highest safe dose that patients could tolerate. Researchers also looked at how the drug affected the cancer and mon…
Phase: PHASE1, PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC